Current Diabetes Reports

, Volume 3, Issue 1, pp 1–3 | Cite as

Medical management of obesity: A clinical imperative?

  • William G. Haynes
Invited Commentary
  • 23 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mokdad AH, Serdula MK, Dietz WH, et al.: The spread of the obesity epidemic in the United States, 1991–1998. JAMA 1999, 282:1519–1522.PubMedCrossRefGoogle Scholar
  2. 2.
    Manson JE, Willett WC, Stampfer MJ, et al.: Body weight and mortality among women. N Engl J Med 1995, 333:677–685.PubMedCrossRefGoogle Scholar
  3. 3.
    Blair SN, Shaten J, Brownell K, et al.: Body weight change, allcause mortality, and cause-specific mortality in the Multiple Risk Factor Intervention Trial. Ann Intern Med 1993, 119:749–775.PubMedGoogle Scholar
  4. 4.
    Sjöström L, Rissanen A, Andersen T, et al.: Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. Lancet 1998, 352:167–172.PubMedCrossRefGoogle Scholar
  5. 5.
    Heymsfield SB, Segal KR, Hauptman J, et al.: Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Arch Intern Med 2000, 160:1321–1326.PubMedCrossRefGoogle Scholar
  6. 6.
    Hollander PA, Elbein SC, Hirsch IB, et al.: Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care 1998, 21:1288–1294.PubMedCrossRefGoogle Scholar
  7. 7.
    Wirth A, Krause J: Long-term weight loss with sibutramine: a randomized controlled trial. JAMA 2001, 286:1331–1339.PubMedCrossRefGoogle Scholar
  8. 8.
    Fujioka K, Seaton TB, Rowe E, et al.: Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus. Diabetes Obes Metab 2000, 2:175–187.PubMedCrossRefGoogle Scholar
  9. 9.
    Fontbonne A, Charles MA, Juhan-Vague I, et al.: The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group. Diabetes Care 1996, 19:920–926.PubMedCrossRefGoogle Scholar
  10. 10.
    Kay JP, Alemzadeh R, Langley G, et al.: Beneficial effects of metformin in normoglycemic morbidly obese adolescents. Metab Clin Exp 2001, 50:1457–1461.PubMedGoogle Scholar

Copyright information

© Current Science Inc. 2003

Authors and Affiliations

  • William G. Haynes
    • 1
  1. 1.General Clinical Research Center (157 MRF)University of IowaIowa CityUSA

Personalised recommendations